The log-rank test was used to compare the survival analysis between anti-AQP4 (+) and anti-AQP4 (-) ABS patients
The log-rank test was used to compare the survival analysis between anti-AQP4 (+) and anti-AQP4 (-) ABS patients. method. The
The log-rank test was used to compare the survival analysis between anti-AQP4 (+) and anti-AQP4 (-) ABS patients. method. The
At equal molar dosages of 10?nM, immunoconjugates with a single, two, and 3 ONC payloads reduced the mean viability of
A subsequent MRI confirmed the solitary great/cystic rim-enhancing lesion in the still left posterior frontal lobe with average vasogenic odema